BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29193594)

  • 1. Complete cure of Fusarium solani sp. complex onychomycosis with Qs NdYAG treatment.
    Khurana A; Chowdhary A; Sardana K; Gautam RK; Sharma PK
    Dermatol Ther; 2018 Mar; 31(2):e12580. PubMed ID: 29193594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct characteristics of Scytalidium dimidiatum and non-dermatophyte onychomycosis as compared with dermatophyte onychomycosis.
    Bunyaratavej S; Prasertworonun N; Leeyaphan C; Chaiwanon O; Muanprasat C; Matthapan L
    J Dermatol; 2015 Mar; 42(3):258-62. PubMed ID: 25639524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.
    Gupta C; Jongman M; Das S; Snehaa K; Bhattacharya SN; Seyedmousavi S; van Diepeningen AD
    Mycopathologia; 2016 Aug; 181(7-8):497-504. PubMed ID: 27138574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fusarium onychomycosis: prevalence, clinical presentations, response to itraconazole and terbinafine pulse therapy, and 1-year follow-up in nine cases.
    Ranawaka RR; Nagahawatte A; Gunasekara TA
    Int J Dermatol; 2015 Nov; 54(11):1275-82. PubMed ID: 26223159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Pulsed 1064-nm Nd:YAG Laser for the Treatment of Onychomycosis.
    Piccolo D; Kostaki D; Del Duca E; Cannarozzo G; Sannino M; Nisticò S
    Photomed Laser Surg; 2017 Apr; 35(4):213-216. PubMed ID: 28061322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-dermatophytic molds as agents of onychomycosis in Izmir, Turkey - a prospective study.
    Hilmioğlu-Polat S; Metin DY; Inci R; Dereli T; Kilinç I; Tümbay E
    Mycopathologia; 2005 Sep; 160(2):125-8. PubMed ID: 16170607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new model of in vitro fungal biofilms formed on human nail fragments allows reliable testing of laser and light therapies against onychomycosis.
    Vila TV; Rozental S; de Sá Guimarães CM
    Lasers Med Sci; 2015 Apr; 30(3):1031-9. PubMed ID: 25471266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onychomycosis in Cameroon: a clinical and epidemiological study among dermatological patients.
    Nkondjo Minkoumou S; Fabrizi V; Papini M
    Int J Dermatol; 2012 Dec; 51(12):1474-7. PubMed ID: 23171013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demonstration of Adventitious Sporulation in Fusarium Petroliphilum Onychomycosis.
    Khan Z; Ahmad S; Alfouzan W; Joseph L; Varghese S
    Mycopathologia; 2019 Apr; 184(2):303-308. PubMed ID: 30734128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Other fungi causing onychomycosis.
    Moreno G; Arenas R
    Clin Dermatol; 2010 Mar; 28(2):160-3. PubMed ID: 20347658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of 1,064-nm long-pulsed Nd:YAG laser in the treatment of severe onychomycosis.
    Kim MS; Jung JY; Cho EB; Park EJ; Kim KH; Kim KJ
    J Cosmet Laser Ther; 2016 Oct; 18(6):317-22. PubMed ID: 27010770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-dermatophyte mold onychomycosis in Sri Lanka.
    Ranawaka RR; de Silva N; Ragunathan RW
    Dermatol Online J; 2012 Jan; 18(1):7. PubMed ID: 22301044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
    Rosa PD; Heidrich D; Corrêa C; Scroferneker ML; Vettorato G; Fuentefria AM; Goldani LZ
    Mycoses; 2017 Sep; 60(9):616-622. PubMed ID: 28657120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical laser treatment of toenail onychomycoses.
    Zalacain A; Merlos A; Planell E; Cantadori EG; Vinuesa T; Viñas M
    Lasers Med Sci; 2018 May; 33(4):927-933. PubMed ID: 28378259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal effects of a 1444-nm neodymium:Yttrium-aluminum-garnet laser on onychomycosis: a pilot study.
    Choi MJ; Zheng Z; Goo B; Cho SB
    J Dermatolog Treat; 2014 Aug; 25(4):294-7. PubMed ID: 22812623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
    Guilhermetti E; Takahachi G; Shinobu CS; Svidzinski TI
    Int J Dermatol; 2007 Aug; 46(8):822-6. PubMed ID: 17651164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ungual hyalohyphomycosis caused by Fusarium proliferatum in an immunocompetent patient.
    Noguchi H; Hiruma M; Matsumoto T; Kano R; Ihn H
    J Dermatol; 2017 Jan; 44(1):88-90. PubMed ID: 27607919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regarding the role of laser therapy in the treatment of onychomycosis: comments on "Morphological and ultrastructural changes in fungal agents after LASER application".
    Alves LRM; Miola AC; Jorge MFS; Miot HA
    Int J Dermatol; 2024 Jun; 63(6):e117-e118. PubMed ID: 38610083
    [No Abstract]   [Full Text] [Related]  

  • 19. 1,064-nm diode laser therapy of onychomycosis: results of a prospective open treatment of 82 toenails.
    Renner R; Grüsser K; Sticherling M
    Dermatology; 2015; 230(2):128-34. PubMed ID: 25662740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusarium solani onychomycosis of the thumbnail coinfected with Pseudomonas aeruginosa: report of two cases.
    Yang YS; Ahn JJ; Shin MK; Lee MH
    Mycoses; 2011 Mar; 54(2):168-71. PubMed ID: 19751392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.